Insulin and insulin-like growth factor receptors in the brain: Physiological and pathological aspects

European Neuropsychopharmacology

Volumn 24, Issue 12, 2014, Pages 1947-1953

  Werner, Haim ^a   LeRoith, Derek ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b Clinical Research Institute at Rambam   (Israel)

Author keywords

Alzheimer's disease; Diabetes; Insulin; Insulin receptors; Insulin like growth factor 1 (IGF 1)

Indexed keywords

GLUCOSE; INSULIN; INSULIN RECEPTOR; SOMATOMEDIN B; SOMATOMEDIN C; SOMATOMEDIN; SOMATOMEDIN RECEPTOR;

ALZHEIMER DISEASE; ANGIOGENESIS; APPETITE; BRAIN FUNCTION; CENTRAL NERVOUS SYSTEM; COGNITION; DIABETES MELLITUS; FOOD INTAKE; HUMAN; LIFESPAN; LIPID METABOLISM; NEUROTRANSMISSION; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SURVIVAL; ANIMAL; BRAIN; DISEASE MODEL; LIFE EXPECTANCY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; APPETITE; BRAIN; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; GLUCOSE; HUMANS; INSULIN; LIFE EXPECTANCY; LIPID METABOLISM; RECEPTOR, INSULIN; RECEPTORS, SOMATOMEDIN; SOMATOMEDINS;

EID: 84903701668     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2014.01.020     Document Type: Review

References (50)

1. Aberg M.A., Aberg N.D., Hedbacker H., Oscarsson J., Eriksson P.S. Peripheral infusion of IGF-I selectively induces neurogenesis in the adult rat hippocampus. J. Neurosci. 2000, 20:2896-2903.
2. Alberini C.M., Chen D.Y. Memory enhancement: consolidation, reconsolidation and insulin-like growth factor 2. Trends Neurosci. 2012, 35:274-283.
3. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., et al. Inflammation and Alzheimer's disease. Neurobiol. Aging 2000, 21:383-421.
4. Baker J., Liu J.P., Robertson E.J., Efstratiadis A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 1993, 75:73-82.
5. Banks W.A., Owen J.B., Erickson M.A. Insulin in the brain: there and back again. Pharmacol. Ther. 2012, 136:82-93.
6. Bates K.A., Verdile G., Li Q.X., Ames D., Hudson P., Masters C.L., Martins R.N. Clearance mechanisms of Alzheimer's amyloid-beta peptide: implications for therapeutic design and diagnostic tests. Mol. Psychiatry 2009, 14:469-486.
7. Bondy C.A., Werner H., Roberts C.T., LeRoith D. Cellular pattern of insulin-like growth factor-I (IGF-I) and type I IGF receptor gene expression in early organogenesis: comparison with IGF-II gene expression. Mol. Endocrinol. 1990, 4:1386-1398.
8. Bondy C.A., Werner H., Roberts C.T., LeRoith D. Cellular pattern of type-I insulin-like growth factor receptor gene expression during maturation of the rat brain: comparison with insulin-like growth factors I and II. Neuroscience 1992, 46:909-923.
9. Carro E., Nunez A., Busiguina S., Torres-Aleman I. Circulating insulin-like growth factor I mediates effects of exercise on the brain. J. Neurosci. 2000, 20:2926-2933.
10. Carro E., Trejo J.L., Spuch C., Bohl D., Heard J.M., Torres-Aleman I. Blockade of the insulin-like growth factor I receptor in the choroid plexus originates Alzheimer's-like neuropathology in rodents: new cues into the human disease?. Neurobiol. Aging 2006, 27:1618-1631.
11. Chen D.Y., Stern S.A., Garcia-Osta A., Saunier-Rebori B., Pollonini G., Bambah-Mukku D., et al. A critical role for IGF-II in memory consolidation and enhancement. Nature 2011, 469:491-497.
12. Clark A., Wells C.A., Buley I.D., Cruickshank J.K., Vanhegan R.I., Matthews D.R., et al. Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Res. 1988, 9:151-159.
13. D'Ercole A.J., Ye P., O'Kusky J.R. Mutant mouse models of insulin-like growth factor actions in the central nervous system. Neuropeptides 2002, 36:209-220.
14. Devaskar S.U., Singh B.S., Carnaghi L.R., Rajakumar P.A., Giddings S.J. Insulin II gene expression in rat central nervous system. Regul. Pept. 1993, 48:55-63.
15. Díaz B., Pimentel B., de Pablo F., de La Rosa E.J. Apoptotic cell death of proliferating neuroepithelial cells in the embryonic retina is prevented by insulin. Eur. J. Neurosci. 1999, 11:1624-1632.
16. Gupta G., Azam M., Baquer N.Z. Modulation of rat brain insulin receptor kinase activity in diabetes. Neurochem. Int. 1992, 20:487-492.
17. Gutierrez-Juarez R., Obici S., Rossetti L. Melanocortin-independent effects of leptin on hepatic glucose fluxes. J. Biol. Chem. 2004, 279:49704-49715.
18. Hallschmid M., Higgs S., Thienel M., Ott V., Lehnert H. Postprandial administration of intranasal insulin intensifies satiety and reduces intake of palatable snacks in women. Diabetes 2012, 61:782-789.
19. Havrankova J., Roth J., Brownstein M. Insulin receptors are widely distributed in the central nervous system of the rat. Nature 1978, 272:827-829.
20. Janson J., Laedtke T., Parisi J.E., O'Brien P., Petersen R.C., Butler P.C. Increased risk of type 2 diabetes in Alzheimer disease. Diabetes 2004, 53:474-481.
21. Kaidanovich O., Eldar-Finkelman H. The role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes. Expert Opin. Ther. Targets 2002, 6:555-561.
22. Kappeler L., De Magalhaes Filho C., Dupont J., Leneuve P., Cervera P., Périn L., et al. Brain IGF-1 receptors control mammalian growth and lifespan through a neuroendocrine mechanism. PLoS Biol. 2008, 6(10):e254.
23. Kopf D., Frolich L. Risk of incident Alzheimer's disease in diabetic patients: a systematic review of prospective trials. J. Alzheimer's Dis. 2009, 16:677-685.
24. Liu H., Yang H., Wang D., Liu Y., Liu X., Li Y., et al. Insulin regulates P-glycoprotein in rat brain microvessel endothelial cells via an insulin receptor-mediated PKC/NF-kappaB pathway but not a PI3K/Akt pathway. Eur. J. Pharmacol. 2009, 602:277-282.
25. Liu J.P., Baker J., Perkins A.S., Robertson E.J., Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor-I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 1993, 75:59-72.
26. Lopez-Lopez, C., LeRoith, D., Torres-Aleman, I., 2004. Insulin-like growth factor I is required for vessel remodeling in the adult brain. Proceedings of the National Academy of Sciences USA, vol. 101, pp. 9833-9838.
27. Luca S., Yau W.M., Leapman R., Tycko R. Peptide conformation and supramolecular organization in amylin fibrils: constraints from solid-state NMR. Biochemistry 2007, 46:13505-13522.
28. Marks D.R., Tucker K., Cavallin M.A., Mast T.G., Fadool D.A. Awake intranasal insulin delivery modifies protein complexes and alters memory, anxiety, and olfactory behaviors. J Neurosci. 2009, 29:6734-6751.
29. Mielke J.G., Taghibiglou C., Wang Y.T. Endogenous insulin signaling protects cultured neurons from oxygen-glucose deprivation-induced cell death. Neuroscience 2006, 143:165-173.
30. Obici S., Zhang B.B., Karkanias G., Rossetti L. Hypothalamic insulin signaling is required for inhibition of glucose production. Nat. Med. 2002, 8:1376-1382.
31. Osborn O., Olefsky J.M. The cellular and signaling networks linking the immun system and metabolism in disease. Nat. Med. 2012, 18:363-374.
32. Plum L., Schubert M., Brüning J.C. The role of insulin receptor signaling in the brain. Trends Endocrinol. Metab. 2005, 16:59-65.
33. Puglielli L. Aging of the brain, neurotrophin signaling and Alzheimer's disease: is IGF1-R the common culprit?. Neurobiol. Aging 2008, 29:795-811.
34. Rivera E.J., Goldin A., Fulmer N., Tavares R., Wands J.R., de la Monte S.M. Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine. J. Alzheimer's Dis. 2005, 8:247-268.
35. Russo V.C., Gluckman P.D., Feldman E.L., Werther G.A. The insulin-like growth factor system and its pleiotropic functions in brain. Endocr. Rev. 2005, 26:916-943.
36. Sato N., Takeda S., Uchio-Yamada K., Ueda H., Fujisawa T., Rakugi H., Morishita R. Role of insulin signaling in the interaction between Alzheimer disease and diabetes mellitus: a missing link to therapeutic potential. Curr. Aging Sci. 2011, 4:118-127.
37. Reger M.A., Watson G.S., Green P.S., Baker L.D., Cholerton B., Fishel M.A., et al. Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults. J. Alzheimer's Dis. 2008, 13:323-331.
38. Scherer T., Buettner C. Yin and Yang of hypothalamic insulin and leptin signaling in regulating white adipose tissue metabolism. Rev. Endocr. Metab. Disord. 2011, 12:235-243.
39. Shemer J., Raizada M.K., Masters B.A., Ota A., LeRoith D. Insulin-like growth factor I receptors in neuronal and glial cells. Characterization and biological effects in primary culture. J. Biol. Chem. 1987, 262:7693-7699.
40. Suh, Y., Atzmon, G., Cho, M.O., Hwang, D., Liu, B., Leahy, D.J., et al., 2008. Functionally significant insulin-like growth factor I receptor mutations in centenarians. Proceedings of the National Academy of Sciences USA, vol. 105, pp. 3438-3442.
41. Suzuki T., Nakaya T. Regulation of amyloid beta-protein precursor by phosphorylation and protein interactions. J. Biol. Chem. 2008, 283:29633-29637.
42. Talbot K., Wang H.Y., Kazi H., Han L.Y., Bakshi K.P., Stucky A., et al. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J. Clin. Investig. 2012, 122:1316-1338.
43. Torres-Aleman I. Towards a comprehensive neurobiology of IGF-I. Dev. Neurobiol. 2010, 70:384-396.
44. Trejo J.L., Piriz J., Llorens-Martin M.V., Fernandez A.M., Bolós M., LeRoith D., et al. Central actions of liver-derived insulin-like growth factor I underlying its pro-cognitive effects. Mol. Psychiatry 2007, 12:1118-1128.
45. Unger J.W., Livingston J.N., Moss A.M. Insulin receptors in the central nervous system: localization, signalling mechanisms and functional aspects. Prog. Neurobiol. 1991, 36:343-362.
46. Unger J., McNeill T.H., Moxley R.T., White M., Moss A., Livingston J.N. Distribution of insulin receptor-like immunoreactivity in the rat forebrain. Neuroscience 1989, 31:143-157.
47. Wyss-Coray T. Inflammation in Alzheimer disease: driving force, bystander or beneficial response?. Nat. Med. 2006, 1:1005-1015.
48. Wozniak M., Rydzewski B., Baker S.P., Raizada M.K. The cellular and physiological actions of insulin in the central nervous system. Neurochem. Int. 1993, 22:1-10.
49. Yang J., Anzo M., Cohen P. Control of aging and longevity by IGF-I signaling. Exp. Gerontol. 2005, 40:867-872.
50. Yang Y., Song W. Molecular links between Alzheimer's disease and diabetes mellitus. Neuroscience 2013, 250:140-150.